Hur JY - Search Results

1

Immunological Characteristics of Hyperprogressive Disease in Patients with Non-small Cell Lung Cancer Treated with Anti-PD-1/PD-L1 Abs.

Kim KH, Hur JY, Koh J, Cho J, Ku BM, Koh JY, Sun JM, Lee SH, Ahn JS, Park K, Ahn MJ, Shin EC. Kim KH, et al. Among authors: hur jy. Immune Netw. 2020 Dec 21;20(6):e48. doi: 10.4110/in.2020.20.e48. eCollection 2020 Dec. Immune Netw. 2020. PMID: 33425433 Free PMC article.

2

The Prognostic Nutritional Index Predicts Survival and Identifies Aggressiveness of Gastric Cancer.

Eo WK, Chang HJ, Suh J, Ahn J, Shin J, Hur JY, Kim GY, Lee S, Park S, Lee S. Eo WK, et al. Among authors: hur jy. Nutr Cancer. 2015;67(8):1260-7. doi: 10.1080/01635581.2015.1082112. Epub 2015 Nov 19. Nutr Cancer. 2015. PMID: 26583916

3

Kim KH, Hur JY, Cho J, Ku BM, Koh J, Koh JY, Sun JM, Lee SH, Ahn JS, Park K, Ahn MJ, Shin EC. Kim KH, et al. Among authors: hur jy. Oncoimmunology. 2020 Feb 2;9(1):1722023. doi: 10.1080/2162402X.2020.1722023. eCollection 2020. Oncoimmunology. 2020. PMID: 32076579 Free PMC article.

4

High-level FGFR2 amplification is associated with poor prognosis and Lower response to chemotherapy in gastric cancers.

Hur JY, Chao J, Kim K, Kim ST, Kim KM, Klempner SJ, Lee J. Hur JY, et al. Pathol Res Pract. 2020 Apr;216(4):152878. doi: 10.1016/j.prp.2020.152878. Epub 2020 Feb 13. Pathol Res Pract. 2020. PMID: 32089408 Free article.

5

Characteristics and Clinical Outcomes of Non-small Cell Lung Cancer Patients in Korea With MET Exon 14 Skipping.

Hur JY, Ku BM, Shim JH, Jung HA, Sun JM, Lee SH, Ahn JS, Park K, Ahn MJ. Hur JY, et al. In Vivo. 2020 May-Jun;34(3):1399-1406. doi: 10.21873/invivo.11920. In Vivo. 2020. PMID: 32354937 Free PMC article.

6

Clinical Characteristics of Korean Breast Cancer Patients Who Carry Pathogenic Germline Mutations in Both BRCA1 and BRCA2: A Single-Center Experience.

Hur JY, Kim JY, Ahn JS, Im YH, Lee J, Kwon M, Park YH. Hur JY, et al. Cancers (Basel). 2020 May 21;12(5):1306. doi: 10.3390/cancers12051306. Cancers (Basel). 2020. PMID: 32455662 Free PMC article.

7

MDSC subtypes and CD39 expression on CD8⁺ T cells predict the efficacy of anti-PD-1 immunotherapy in patients with advanced NSCLC.

Koh J, Kim Y, Lee KY, Hur JY, Kim MS, Kim B, Cho HJ, Lee YC, Bae YH, Ku BM, Sun JM, Lee SH, Ahn JS, Park K, Ahn MJ. Koh J, et al. Among authors: hur jy. Eur J Immunol. 2020 Nov;50(11):1810-1819. doi: 10.1002/eji.202048534. Epub 2020 Jul 9. Eur J Immunol. 2020. PMID: 32510574 Free PMC article.

8

Regulatory (FoxP3⁺) T cells and TGF-β predict the response to anti-PD-1 immunotherapy in patients with non-small cell lung cancer.

Koh J, Hur JY, Lee KY, Kim MS, Heo JY, Ku BM, Sun JM, Lee SH, Ahn JS, Park K, Ahn MJ. Koh J, et al. Among authors: hur jy. Sci Rep. 2020 Nov 4;10(1):18994. doi: 10.1038/s41598-020-76130-1. Sci Rep. 2020. PMID: 33149213 Free PMC article.

9

Prognostic value of FOXP3+ regulatory T cells for patients with locally advanced oropharyngeal squamous cell carcinoma.

Hur JY, Ku BM, Park S, Jung HA, Lee SH, Ahn MJ. Hur JY, et al. PLoS One. 2022 Oct 6;17(10):e0274830. doi: 10.1371/journal.pone.0274830. eCollection 2022. PLoS One. 2022. PMID: 36201479 Free PMC article.

10

Preoperative plateletcrit is a Prognostic Biomarker for Survival in Patients with Non-Small Cell Lung Cancer.

Hur JY, Lee HY, Chang HJ, Choi CW, Kim DH, Eo WK. Hur JY, et al. J Cancer. 2020 Feb 25;11(10):2800-2807. doi: 10.7150/jca.41122. eCollection 2020. J Cancer. 2020. PMID: 32226498 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

147 results

Search Page

Filters